Ankylosing Spondylitis Drugs Market Size, Share, Key Players, Growth Trend, and Forecast, 2022–2032
The ankylosing spondylitis drugs market globally reached USD 7.25 billion in 2022 and is anticipated to reach USD 13.33 billion by 2032, with a projected revenue compound annual growth rate (CAGR) of 7% during the forecast period. The increasing prevalence of ankylosing spondylitis, coupled with a growing demand for safe and effective treatment options and improved awareness about the...
0 Commentaires
0 Parts
5636 Vue